Which laboratory tests should be ordered to confirm a diagnosis of SIADH and exclude mimicking conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Workup to Confirm SIADH and Exclude Mimics

Order serum sodium, serum osmolality, urine osmolality, urine sodium, serum uric acid, and assess volume status; these core tests distinguish SIADH from cerebral salt wasting and other hyponatremic conditions. 1

Essential Initial Laboratory Tests

When serum sodium falls below 131 mmol/L, obtain the following panel 1:

Core Diagnostic Tests

  • Serum sodium - confirms hyponatremia
  • Serum osmolality - must be low (<280 mOsm/kg) to proceed; normal/high values suggest pseudohyponatremia from hyperglycemia or hypertriglyceridemia
  • Urine osmolality - inappropriately elevated (typically >100 mOsm/kg, often >300 mOsm/kg) in SIADH 2
  • Urine sodium - typically >30 mmol/L in SIADH, though can be lower with poor oral intake 1, 3
  • Serum uric acid - a level <4 mg/dL has 73-100% positive predictive value for SIADH 1
  • Serum urea/BUN - characteristically low in SIADH due to volume expansion 2

Volume Status Assessment

Physical examination alone is inadequate (sensitivity only 41%, specificity 80%) for determining volume status 1. The key distinction is between SIADH (euvolemic) and cerebral salt wasting (hypovolemic), as this determines whether to restrict or replace fluids.

Consider central venous pressure (CVP) measurement when volume status is unclear 1:

  • CVP 6-10 cm H₂O = euvolemic (SIADH)
  • CVP <5-6 cm H₂O = hypovolemic (cerebral salt wasting)

Advanced Discriminatory Tests

Fractional Excretion Calculations

Fractional excretion of uric acid (FE-UA) is the most accurate diagnostic marker for SIADH 4:

  • FE-UA >12% strongly suggests SIADH 4
  • FE-UA <5% after partial sodium correction favors cerebral/renal salt wasting 5
  • More reliable than fractional excretion of sodium (FE-Na), though FE-Na >0.5% occurs in 70% of SIADH cases 2

Additional Supportive Markers

  • Serum anion gap - typically lower in SIADH with near-normal total CO₂ and potassium despite dilution 2
  • Fractional excretion of phosphate - can help differentiate SIADH from cerebral salt wasting 6

Tests to Exclude Mimicking Conditions

Rule Out These Conditions First

  • Thyroid function tests (TSH, free T4) - exclude hypothyroidism
  • Morning cortisol or ACTH stimulation test - exclude adrenal insufficiency (note: hypocorticism shows lower total CO₂ than non-endocrine SIADH despite similar urea/uric acid) 2
  • Review medication list - exclude diuretic use before proceeding 1

Critical Pitfalls to Avoid

  1. Do not rely on ADH levels - they have limited diagnostic value; SIADH can occur with undetectable ADH 1

  2. Urine sodium <30 mmol/L does not exclude SIADH - this can occur with poor oral intake; the 71-100% positive predictive value for saline responsiveness applies to non-neurosurgical patients 1

  3. Low uric acid is not 100% specific - 40% of salt-depleted patients also have low uric acid, though 70% of SIADH patients do 2

  4. In acute symptomatic hyponatremia, prioritize rapid correction over complete diagnostic workup 7

Practical Diagnostic Algorithm

For hyponatremia <131 mmol/L with low serum osmolality:

  1. Check urine osmolality: If <100 mOsm/kg → polydipsia or reset osmostat 2
  2. Check urine sodium: If <30 mmol/L → consider hypovolemia (but not definitive)
  3. Check serum uric acid: If <4 mg/dL → strongly favors SIADH 1
  4. Calculate FE-UA: If >12% → confirms SIADH 4
  5. Assess volume status clinically + CVP if available: Distinguishes SIADH from cerebral salt wasting 1
  6. Exclude thyroid/adrenal dysfunction and medications

In neurosurgical patients specifically, the combination of physical examination findings and laboratory tests is essential because both SIADH and cerebral salt wasting present with natriuresis 1.

Related Questions

In a patient with mild hyponatremia, how can serum blood urea nitrogen (BUN) and uric acid levels be used to differentiate syndrome of inappropriate antidiuretic hormone secretion (SIAD) from hypovolemia?
What type of hyponatremia does my patient have given severe hyponatremia, hypotonic serum osmolality, low urine sodium, and low uric acid?
How should I interpret the fractional excretion of urea in a patient with suspected syndrome of inappropriate antidiuretic hormone secretion (SIADH)?
Is a complete blood count (CBC) and comprehensive metabolic panel (CMP) sufficient to diagnose syndrome of inappropriate antidiuretic hormone secretion (SIADH)?
In a 45-year-old man with type 1 diabetes, gastroparesis, persistent nausea, normal exam, serum sodium 123 mmol/L, and no excess water intake or diuretic use, which laboratory parameter is consistent with syndrome of inappropriate antidiuretic hormone secretion (SIADH)?
What is the recommended imaging interval for a thoracic ascending aortic aneurysm based on its size and growth rate?
In a non‑pregnant adult without severe liver or kidney disease or doxycycline allergy, what is the appropriate doxycycline post‑exposure prophylaxis regimen for bacterial sexually transmitted infections?
In a patient who has undergone thyroidectomy and is taking levothyroxine, what could cause an elevated thyroid‑stimulating hormone (TSH) together with an elevated free thyroxine (free T4) level?
Based on a family history of baldness (both grandfathers bald, maternal uncle with partial male‑pattern baldness, father not bald), what is the patient’s risk of developing androgenetic (male‑pattern) alopecia?
What medication can be given to relieve abdominal quivering when promethazine (Phenergan) and ondansetron (Zofran) have failed?
What is the appropriate management for a patient taking vilazodone (starting at 10 mg daily, up to 40 mg) who develops new visual disturbances?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.